These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26385119)

  • 1. Posterior Reversible Encephalopathy Syndrome in Early-Stage Breast Cancer.
    Ladwa R; Peters G; Bigby K; Chern B
    Breast J; 2015; 21(6):674-7. PubMed ID: 26385119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!!
    Roy S; Gandhi AK; Jana M; Julka PK
    J Cancer Res Ther; 2014; 10(2):393-6. PubMed ID: 25022403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome (PRES) after combination chemotherapy for lymphoma.
    Ramachandran A; Klein R
    Am J Ther; 2014; 21(5):e137-42. PubMed ID: 23075577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
    Battipaglia G; Avilia S; Morelli E; Caranci F; Perna F; Camera A
    Ann Hematol; 2012 Aug; 91(8):1327-8. PubMed ID: 22237936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases].
    Chanal E; Bouleftour W; Rivoirard R; Bosaki C; Forges F; Jacquin JP; Fournel P; Mery B; Saban-Roche L
    Presse Med; 2019 Oct; 48(10):1026-1031. PubMed ID: 31653541
    [No Abstract]   [Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab.
    Cooksley T; Haji-Michael P
    J R Coll Physicians Edinb; 2011 Sep; 41(3):215-7. PubMed ID: 21949916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible posterior leukoencephalopathy syndrome after carboplatin and paclitaxel regimen for lung cancer.
    Imai H; Okuno N; Ishihara S; Nakano S; Higuchi S; Arai T; Tokunaga M; Kobayashi H; Arai T; Mori M
    Intern Med; 2012; 51(8):911-5. PubMed ID: 22504249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant lymphoma complicated with posterior reversible encephalopathy].
    Thomsen RH; Zakarian K; Hansen PB
    Ugeskr Laeger; 2015 Sep; 177(37):V03150236. PubMed ID: 26376238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.
    Femia G; Hardy TA; Spies JM; Horvath LG
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):115-22. PubMed ID: 22524570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversible posterior leukoencephalopathy post-chemotherapy with carboplatin and paclitaxel].
    Jamelot M; Fontanilles M; Vaschalde Y
    Bull Cancer; 2019 Dec; 106(12):1191-1195. PubMed ID: 31472945
    [No Abstract]   [Full Text] [Related]  

  • 11. Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer.
    Turner N; Stewart J; Barnett F; White S
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):e9-e11. PubMed ID: 22897880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).
    Janjua TK; Hassan M; Afridi HK; Zahid NA
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil.
    Truman N; Nethercott D
    Clin Colorectal Cancer; 2013 Mar; 12(1):70-2. PubMed ID: 22917935
    [No Abstract]   [Full Text] [Related]  

  • 14. Early Recognition and Management of Posterior Reversible Encephalopathy Syndrome: A Newly Recognized Complication in Patients Receiving Tyrosine Kinase Inhibitors.
    Przybylyski A; Esper P
    Clin J Oncol Nurs; 2016 Jun; 20(3):305-8. PubMed ID: 27206297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!
    Khurana A; Dasanu CA
    J Oncol Pharm Pract; 2015 Dec; 21(6):443-50. PubMed ID: 25013187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.
    Chen YH; Huang CH
    Clin Breast Cancer; 2012 Jun; 12(3):222-5. PubMed ID: 22424944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.
    Ryan SA; Maceneaney P; O'Reilly SP; Moylan EJ; Power DG
    Med Oncol; 2012 Jun; 29(2):1287-91. PubMed ID: 21390516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.
    Bürki F; Badie K; Bartoli P; Bernard P; Montastruc JL; Bagheri H
    Br J Clin Pharmacol; 2008 May; 65(5):793-4. PubMed ID: 18279475
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment.
    Chang HR; Glaspy J; Allison MA; Kass FC; Elashoff R; Chung DU; Gornbein J
    Cancer; 2010 Sep; 116(18):4227-37. PubMed ID: 20549829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.